Achillion Pharmaceuticals said that a regimen intended to treat hepatitis C patients showed strong results amid an increasingly competitive market for drugs to fight the disease
via WSJ.com: US Business http://ift.tt/13wDiW9
via WSJ.com: US Business http://ift.tt/13wDiW9
Nessun commento:
Posta un commento